Clinical update in genetics and endocrinology – Part 2

Márta Korbonits, MD, PhD, DSc, FRCP is Professor of Endocrinology and Metabolism at Barts and the London School of Medicine and Dentistry, Queen Mary University of London, is a graduate from the Semmelweis Medical School, Budapest. She was a Medical Research Council Clinician Scientist Fellow working on ghrelin and the hormonal regulation of the metabolic enzyme AMP-activated protein kinase. Her current interests include endocrine tumorigenesis, especially the genetic origin of pituitary adenomas and other endocrine tumour syndromes.

She works on both the clinical characterisation as well as molecular aspects of pituitary diseases and leads a large international consortium to study these rare conditions. She published over 200 original papers (Scopus H-index of 62). She shares her time between clinical patient care, clinical research and laboratory-based research as well as teaching at undergraduate and postgraduate level. She was a recipient of several national and international awards and was serving on the Executive Committee of ENEA, SfE and ESE as well as on several editorial boards. She is the incoming Deputy Editor of Endocrine-Related Cancer. In 2019 she has been elected as a Member of the Hungarian Academy of Sciences.

Dr Ruth Casey is a Consultant Endocrinologist in Cambridge University Hospital NHS Foundation Trust and holds an academic position as a senior research associate in the Department of Medical Genetics, Cambridge University. Dr Casey leads neuroendocrine tumour (NET) and endocrine cancer services in Cambridge and is the endocrine lead for the endocrine genetics service, encompassing both clinical practice and independently funded research in GIST, phaeochromocytoma, paraganglioma and neuroendocrine tumours. She has a specialist research interest in SDH deficient tumours and the molecular mechanisms underpinning endocrine cancers.

Dr Paul Newey is a Senior Lecturer and Honorary Consultant Physician at the University of Dundee. He undertook his medical training in Edinburgh and Oxford. His current research employs clinical, genetic and molecular approaches to investigate endocrine tumour formation. He has a particular clinical interest in several Hereditary Endocrine disorders including the Multiple Endocrine Neoplasia (MEN) syndromes.